Rescue of impaired late?phase long-term depression in a tau transgenic mouse model, Neurobiology of Aging, vol.36, issue.2, pp.730-739, 2015. ,
An N-methyl-d-aspartate-receptor dependent, late-phase long-term depression in middle-aged mice identifies no GluN2-subunit bias, Neuroscience, vol.185, pp.27-38, 2011. ,
Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease, Acta Neuropathologica, vol.103, issue.1, pp.26-35, 2001. ,
Bizarre behaviors and risk assessment in 3xTg-AD mice at early stages of the disease, Behavioural Brain Research, vol.258, pp.97-105, 2014. ,
Does cAMP Response Element-Binding Protein Have a Pivotal Role in Hippocampal Synaptic Plasticity and Hippocampus-Dependent Memory?, The Journal of Neuroscience, vol.23, issue.15, pp.6304-6314, 2003. ,
Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimers Disease, Current Alzheimer Research, vol.6, issue.2, pp.152-157, 2009. ,
Regulation and function of selenoproteins in human disease, Biochemical Journal, vol.422, issue.1, pp.11-22, 2009. ,
A role for tau in learning, memory and synaptic plasticity, Scientific Reports, vol.8, issue.1, p.3184, 2018. ,
Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy, Alzheimer's Research & Therapy, vol.9, issue.1, p.77, 2017. ,
Chapter 20 Neuropathological hallmarks of Alzheimer's and Parkinson's diseases, Progress in Brain Research, vol.117, pp.267-285, 1998. ,
Tau and A? imaging, CSF measures, and cognition in Alzheimer?s disease, Science Translational Medicine, vol.8, issue.338, pp.338ra66-338ra66, 2016. ,
Selenium and cancer: from prevention to treatment, Klin. Onkol, vol.24, pp.171-179, 2011. ,
From tau phosphorylation to tau aggregation: what about neuronal death?, Biochemical Society Transactions, vol.38, issue.4, pp.967-972, 2010. ,
NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model, Aging Cell, vol.12, issue.1, pp.11-23, 2012. ,
Cognitive and emotional alterations in young Alzheimer's disease (3xTgAD) mice: Effects of neonatal handling stimulation and sexual dimorphism, Behavioural Brain Research, vol.281, pp.156-171, 2015. ,
Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer?s Disease, Neurotherapeutics, vol.16, issue.1, pp.192-202, 2018. ,
Tau-targeting therapies for Alzheimer disease, Nature Reviews Neurology, vol.14, issue.7, pp.399-415, 2018. ,
Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer, British Journal of Cancer, vol.103, issue.4, pp.462-468, 2010. ,
Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer?s disease model, Journal of Clinical Neuroscience, vol.17, issue.8, pp.1025-1033, 2010. ,
Substrate-specific reduction of PP2A activity exaggerates tau pathology, Biochemical and Biophysical Research Communications, vol.379, issue.2, pp.400-405, 2009. ,
The Prevalence and Incidence of Dementia Due to Alzheimer?s Disease: a Systematic Review and Meta-Analysis, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, vol.43, issue.S1, pp.S51-S82, 2016. ,
Synaptic Impairment in Alzheimer?s Disease: A Dysregulated Symphony, Trends in Neurosciences, vol.40, issue.6, pp.347-357, 2017. ,
Tau phosphorylation in the mouse brain during aversive conditioning, Neurochemistry International, vol.51, issue.2-4, pp.200-208, 2007. ,
Differences in behavioural test battery performance between mice with hippocampal and cerebellar lesions, Behavioural Brain Research, vol.173, issue.1, pp.138-147, 2006. ,
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Annals of Neurology, vol.41, issue.1, pp.17-24, 1997. ,
The Prevalence and Incidence of Frontotemporal Dementia: a Systematic Review, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, vol.43, issue.S1, pp.S96-S109, 2016. ,
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration, Neuron, vol.68, issue.6, pp.1067-1081, 2010. ,
Biochemical analysis of selenoprotein expression in brain cell lines and in distinct brain regions, Cell and Tissue Research, vol.332, issue.3, pp.403-414, 2008. ,
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease, Alzheimer's & Dementia, vol.8, issue.1, pp.1-13, 2012. ,
Sodium selenate activated Wnt/?-catenin signaling and repressed amyloid-? formation in a triple transgenic mouse model of Alzheimer's disease, Experimental Neurology, vol.297, pp.36-49, 2017. ,
Metabolic changes over the course of aging in a mouse model of tau deposition, Neurobiology of Aging, vol.44, pp.62-73, 2016. ,
Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model, Journal of Alzheimer's Disease, vol.49, issue.3, pp.783-795, 2015. ,
Reduced protein phosphatase 2A activity induces hyperphosphorylation and altered compartmentalization of tau in transgenic mice, J. Biol. Chem, vol.276, pp.38193-38200, 2001. ,
Activation of the ERK and JNK Signaling Pathways Caused by Neuron-Specific Inhibition of PP2A in Transgenic Mice, The American Journal of Pathology, vol.163, issue.3, pp.833-843, 2003. ,
Behavioural and psychological symptoms of dementia in mouse models of Alzheimer?s disease-related pathology, Neuroscience & Biobehavioral Reviews, vol.112, pp.634-647, 2020. ,
GSK3 and Alzheimer?s disease: facts and fiction?, Frontiers in Molecular Neuroscience, vol.4, p.17, 2011. ,
Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases, Methods in Molecular Biology, vol.1053, pp.283-305, 2013. ,
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology, Neurobiology of Aging, vol.35, issue.9, pp.2079-2090, 2014. ,
Detrimental Effects of Diet-Induced Obesity on Pathology Are Independent of Insulin Resistance in Transgenic Mice, Diabetes, vol.62, issue.5, pp.1681-1688, 2012. ,
Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation, European Journal of Neuroscience, vol.22, issue.8, pp.1942-1950, 2005. ,
Selenium and Alzheimer's Disease: A Systematic Review, Journal of Alzheimer's Disease, vol.26, issue.1, pp.81-104, 2011. ,
Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy, Neurobiology of Disease, vol.47, issue.1, pp.1-12, 2012. ,
Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma, Clinical Pharmacology & Therapeutics, vol.107, issue.1, pp.79-81, 2019. ,
Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti?tau antibody AT8, Proteins: Structure, Function, and Bioinformatics, vol.84, issue.4, pp.427-434, 2016. ,
A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer?s Disease, Journal of Alzheimer's Disease, vol.54, issue.1, pp.223-232, 2016. ,
Tau protein kinases: Involvement in Alzheimer's disease, Ageing Research Reviews, vol.12, issue.1, pp.289-309, 2013. ,
Alzheimer's disease, Nature Reviews Disease Primers, vol.1, issue.1, p.15056, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01723790
Homocysteine and Alzheimer's disease, The Lancet Neurology, vol.2, issue.7, pp.425-428, 2003. ,
Understanding the impact of sex and gender in Alzheimer's disease: A call to action, Alzheimer's & Dementia, vol.14, issue.9, pp.1171-1183, 2018. ,
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature, Journal of Neuropathology & Experimental Neurology, vol.71, issue.5, pp.362-381, 2012. ,
Transgenic Mice Lacking NMDAR-Dependent LTD Exhibit Deficits in Behavioral Flexibility, Neuron, vol.58, issue.1, pp.104-117, 2008. ,
PP2A methylation controls sensitivity and resistance to ?-amyloid?induced cognitive and electrophysiological impairments, Proceedings of the National Academy of Sciences, vol.113, issue.12, pp.3347-3352, 2016. ,
The epidemiology of frontotemporal dementia, International Review of Psychiatry, vol.25, issue.2, pp.130-137, 2013. ,
Network abnormalities and interneuron dysfunction in Alzheimer disease, Nature Reviews Neuroscience, vol.17, issue.12, pp.777-792, 2016. ,
Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of Protein Following Onset of Diabetes in NOD Mice, Diabetes, vol.62, issue.2, pp.609-617, 2012. ,
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer?s Disease, Cell Reports, vol.29, issue.11, pp.3592-3604.e5, 2019. ,
Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease., Behavioral Neuroscience, vol.122, issue.4, pp.733-747, 2008. ,
Selenoproteins in Nervous System Development and Function, Biological Trace Element Research, vol.161, issue.3, pp.231-245, 2014. ,
Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia, Neuroscience Letters, vol.631, pp.24-29, 2016. ,
PP2A Regulates Tau Phosphorylation Directly and also Indirectly via Activating GSK-3?, Journal of Alzheimer's Disease, vol.19, issue.4, pp.1221-1229, 2010. ,
Alzheimer's Disease, New England Journal of Medicine, vol.362, issue.4, pp.329-344, 2010. ,
Selenium and human health, The Lancet, vol.379, issue.9822, pp.1256-1268, 2012. ,
A Novel Triple Repeat Mutant Tau Transgenic Model That Mimics Aspects of Pick?s Disease and Fronto-Temporal Tauopathies, PLOS ONE, vol.10, issue.3, p.e0121570, 2015. ,
Editorial: Alzheimer's disease drug development pipeline 2020, J. Prev. Alzheimers Dis, vol.7, pp.66-67, 2020. ,
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function, Science, vol.309, issue.5733, pp.476-481, 2005. ,
Alzheimer's disease, The Lancet, vol.388, issue.10043, pp.505-517, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01723790
Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits, The American Journal of Pathology, vol.169, issue.2, pp.599-616, 2006. ,
Alzheimer's Disease Is a Synaptic Failure, Science, vol.298, issue.5594, pp.789-791, 2002. ,
Biochemistry of Tau in Alzheimer?s disease and related neurological disorders, Expert Review of Proteomics, vol.5, issue.2, pp.207-224, 2008. ,
Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury, Brain, vol.138, issue.5, pp.1297-1313, 2015. ,
Selenomethionine Ameliorates Cognitive Decline, Reduces Tau Hyperphosphorylation, and Reverses Synaptic Deficit in the Triple Transgenic Mouse Model of Alzheimer's Disease, Journal of Alzheimer's Disease, vol.41, issue.1, pp.85-99, 2014. ,
Protein phosphatase 2A: the Trojan Horse of cellular signaling, Cellular Signalling, vol.13, issue.1, pp.7-16, 2001. ,
Downregulation of Protein Phosphatase 2A Carboxyl Methylation and Methyltransferase May Contribute to Alzheimer Disease Pathogenesis, Journal of Neuropathology & Experimental Neurology, vol.63, issue.10, pp.1080-1091, 2004. ,
Altered Expression Levels of the Protein Phosphatase 2A AB?C Enzyme Are Associated with Alzheimer Disease Pathology, Journal of Neuropathology & Experimental Neurology, vol.63, issue.4, pp.287-301, 2004. ,
Regulation of the Phosphorylation State and Microtubule-Binding Activity of Tau by Protein Phosphatase 2A, Neuron, vol.17, issue.6, pp.1201-1207, 1996. ,
Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules, Journal of Biological Chemistry, vol.274, issue.36, pp.25490-25498, 1999. ,
Protein phosphatase 2A dysfunction in Alzheimerâ??s disease, Frontiers in Molecular Neuroscience, vol.7, p.16, 2014. ,
Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells, Journal of Neurochemistry, vol.115, issue.6, pp.1455-1465, 2010. ,
Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells, Journal of Biological Chemistry, vol.288, issue.38, pp.27396-27405, 2013. ,
Recognition memory and the medial temporal lobe: a new perspective, Nature Reviews Neuroscience, vol.8, issue.11, pp.872-883, 2007. ,
Early phosphorylation of tau in Alzheimer?s disease occurs at Ser-202 and is preferentially located within neurites, NeuroReport, vol.5, issue.17, pp.2358-2362, 1994. ,
Tau-Induced Defects in Synaptic Plasticity, Learning, and Memory Are Reversible in Transgenic Mice after Switching Off the Toxic Tau Mutant, Journal of Neuroscience, vol.31, issue.7, pp.2511-2525, 2011. ,
The synaptic plasticity and memory hypothesis: encoding, storage and persistence, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.369, issue.1633, p.20130288, 2014. ,
Protein phosphatase 2A and tau: an orchestrated ?Pas de Deux?, FEBS Letters, vol.592, issue.7, pp.1079-1095, 2017. ,
Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation, FEBS Letters, vol.579, issue.25, pp.5704-5712, 2005. ,
Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits, The EMBO Journal, vol.19, issue.21, pp.5682-5691, 2000. ,
Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease, FEBS Letters, vol.518, issue.1-3, pp.1-4, 2002. ,
Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory and attenuated late-phase long-term depression of synaptic transmission, Neurobiol. Learn. Mem, vol.95, pp.296-304, 2011. ,
Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia, Behavioural Brain Research, vol.242, pp.34-39, 2013. ,
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau, Acta Neuropathologica, vol.123, issue.6, pp.787-805, 2012. ,
Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice, Scientific Reports, vol.8, issue.1, p.6431, 2018. ,
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models, Proceedings of the National Academy of Sciences, vol.107, issue.31, pp.13888-13893, 2010. ,
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy, PLOS ONE, vol.13, issue.4, p.e0195486, 2018. ,
Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy, Scientific Reports, vol.7, issue.1, p.43198, 2017. ,
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer?s disease and other tauopathies, Acta Neuropathologica Communications, vol.8, issue.1, p.88, 2020. ,
Ebselen ameliorates ?-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer?s disease mice, JBIC Journal of Biological Inorganic Chemistry, vol.22, issue.6, pp.851-865, 2017. ,
Structure of a Protein Phosphatase 2A Holoenzyme: Insights into B55-Mediated Tau Dephosphorylation, Molecular Cell, vol.31, issue.6, pp.873-885, 2008. ,
Glycogen synthase kinase-3? regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1, FEBS Letters, vol.586, issue.16, pp.2522-2528, 2012. ,
Selenomethionine reduces the deposition of beta-amyloid plaques by modulating ?-secretase and enhancing selenoenzymatic activity in a mouse model of Alzheimer's disease, Metallomics, vol.8, issue.8, pp.782-789, 2016. ,
Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model, The Journal of Neuroscience, vol.37, issue.9, pp.2449-2462, 2017. ,